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IgG4-related disease is characterized by lymphoplasmacytic inflammation and fibrosis, often leading to mass-forming lesions
in different organs. When IgG4-related disease affects the bile ducts, it is called IgG4-related sclerosing cholangitis. A 74-
year-old male complained of dysphagia and abdominal pain. Endoscopic retrograde cholangiography and magnetic resonance
cholangiography revealed bile duct changes suspicious of a bile duct carcinoma or cholangitis. Liver biopsy showed storiform
fibrosis, lymphoplasmacytic infiltration, obliterative phlebitis, and a portal-based inflammatory nodule with expansion of a portal
tract. Hot spots revealed 339 IgG4-positive cells per high power field (HPF) and an IgG4/IgG ratio of 72%. Eight months earlier,
an inguinal lymph node had been removed, showing expanded interfollicular zones and increased plasma cells. Hot spots revealed
593 IgG4-positive cells and an IgG4/IgG ratio of 92%. The serum IgG4 of the patient was elevated nearly 10 times upper limit of
normal. The diagnosis of IgG4-related sclerosing cholangitis associated with IgG4-related lymphadenopathy was made. There was
good response to treatment with prednisolone and azathioprine. The differentiation of IgG4-related sclerosing cholangitis from
primary sclerosing cholangitis and bile duct carcinoma is often difficult. Liver biopsy only rarely contributes to this setting, but we
describe and report in detail a case where liver biopsy showed a portal-based inflammatory nodule with the characteristic features
of this disease.
1. Introduction
IgG4-related disease (IgG4-RD) has a broad spectrum of
clinical manifestations, depending on which organ sys-
tems are involved. This disorder is characterized by fibro-
inflammatory activity that may present as mass-forming
lesions. The condition can affect one or multiple organs at
the same time and is associated with elevated serum IgG4
in most cases [1–4]. The diagnosis of IgG4-RD depends
on close collaboration between the treating physicians, the
radiologist, and the pathologist. Histologically, lesions in
IgG4-RD are characterized by a dense lymphoplasmacytic
infiltrate, storiform fibrosis, and obliterative phlebitis. If
several of these features are present and changes inconsistent
with IgG4-RD are lacking, the diagnosis is further supported
by documentation of increased numbers of IgG4-positive
plasma cells as well as a ratio of IgG4- over IgG-positive cells
above 40 % [1].
When IgG4-RD affects the bile ducts, it goes under the
term IgG4-related sclerosing cholangitis (IgG4-SC). In some
cases the differential diagnosis of IgG4-SC is complicated
by its high degree of clinical and radiologic resemblance to
primary sclerosing cholangitis (PSC) and bile duct carcinoma
[5]. The current diagnostic criteria for IgG4-SC consist of
cholangiography, serum IgG4, other organ manifestations of
IgG4-RD, and characteristic histopathological features [6].
The task of differentiating between these entities is of high
importance, as IgG4-SC responds to steroid treatment unlike
PSC and bile duct carcinoma [2, 7]. In most cases of IgG4-
SC, the characteristic histopathologic lesions are located
in the hilar large bile ducts, with or without involvement
of the common bile duct (CBD) or the intrahepatic bile
ducts. Interestingly, in some IgG4-SC studies an expansive
portal-based inflammatory nodule formed by fibrosis and
inflammation has been recognized [7, 8]. This lesion is
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only identified in a minority of IgG4-SC cases at liver core
needle biopsy (CNB), partly because involvement of the small
peripheral bile ducts only occurs in about 20% of cases
[2, 8]. With this case report, we aimed to present the liver
biopsy features of IgG4-SC involving the small intrahepatic
bile ducts, where liver biopsy was crucial in establishing the
diagnosis.
2. Case Presentation
A 74-year-old male complained of dysphagia and abdominal
pain lasting for two months. Esophagogastroduodenoscopy
revealed esophageal candida infection that was treated with
nystatin, a drug that has not been reported as causing
hepatic injury. He had a history of arterial hypertension,
prostatic hypertrophy, yet unspecified myopathy causing
walking-disabilities for 40 years, and diabetes mellitus type
2 diagnosed four years prior to debut of the gastrointestinal
symptoms. For the past 55 years he had smoked 20 cigarettes
a day and had an alcohol consumption of 21 units (252 g) a
week. Four and a half and one and a half years earlier, he had
undergone surgical removal of amalignant melanomaClark’s
level 2 from his left cheek and a basal cell carcinoma from his
back. Two months earlier, a benign inguinal lymph node as
well as nine colonic hyperplastic polyps had been removed.
The lymph node was detected by physical examination as part
of the follow-up program for malignant melanoma and was
also seen at positron-emission tomography (PET).
After treatment of the esophageal infection, his condition
got worse and he developed jaundice as well as anemia.
Dysphagia and abdominal pain continued and his appetite
decreased. Furthermore, he developed weight loss, light-
colored stools, dark-colored urine, diarrhea, and fatigue. An
abdominal ultrasound showed gallbladder sludge, a poorly
outlined and hypoechoic pancreas, and a dilated common
bile duct, 8.7 mm in diameter. These findings aroused
suspicion of gallstone-related cholecystitis. Additionally,
abdominal contrast-enhanced computed tomography (c-CT)
showed that the CBD had a diameter of 11 mm, intrahepatic
cholestasiswith stenosis at the hepatic duct bifurcation, a liver
cyst located to segment 8, a right-sided renal tumor classified
as Bosniak 3, pancreatic calcifications, and a presumed
benign cyst located to the pancreatic neck. Serological tests
revealed C-reactive protein (CRP) 79 mg/L [< 6 mg/L],
hemoglobin 6.6 mmol/L [8,3-10,5 mmol/L], elevated alanine
aminotransferase (ALT) 164 U/L [10-70 U/L], bilirubin 252
𝜇mol/L [5-25 𝜇mol/L], and alkaline phosphatase (AP) 500
U/L [35-105 U/L)]. The amylase was not elevated. The
elevation of CRP was due to a urinary tract infection, and
E. coli was isolated from the peripheral blood. He was
treated with antibiotics, whereafter the CRP normalized and
the hemoglobin almost normalized (7.4 mmol/L). After two
failed attempts of endoscopic retrograde cholangiopancre-
aticography (ERCP), a magnetic resonance cholangiopancre-
aticography (MRCP) revealed a normalmain pancreatic duct,
intrahepatic cholestasis, and bile duct changes suspicious of
a bile duct carcinoma Bismuth-Corlette type IV in the hilar
region, involving both the right and left hepatic bile ducts.
By magnetic resonance imaging (MRI), no hepatic tumors or
pseudotumors but a benign cyst were observed (Figure 1(a)).
One month later, an ERCP showed multiple strictures of
the small intrahepatic bile ducts in several liver segments,
dilation of the CBD (12mm), and a stenosis of the bifurcation
(Figure 1(b)). Unfortunately, it was not possible to perform
ERCP guided biopsy, for technical reasons. A stent was
placed, and one week later, liver enzymes had improved: ALT
56 U/L, bilirubin 134 𝜇mol/L, and AP 343 U/L. Serum cancer
associated antigen 19-9 (CA 19-9) was strongly elevated to
3003 kU/L [0-37 kU/L] but dropped to 165 kU/L after stent
placement. Hereafter, either a bile duct carcinoma or PSCwas
suspected. Bile duct brush cytology revealed inflammation
and atypical cells. Additional blood tests showed strongly
elevated IgG4 (12.9 g/L, [0.052-1.40 g/L]), elevated IgG (25.69
g/L, [6.1-15.7 g/L]), negative cytoplasmic and perinuclear
neutrophil cytoplasmic antibodies (c-ANCA and p-ANCA),
and positive IgM rheumatoid factor. Serologic markers con-
cerning viral hepatitis aswell as anti-smooth-muscle antibod-
ies, anti-liver-kidney microsome type 1 (LKM1) antibodies,
anti-mitochondrial antibodies (AMA), glomerular basement
membrane antibodies (GBM), liver cytosol specific antibody
type 1 (anti-LC1), and anti-nuclear antibodies were all nega-
tive. He had a normal glomerular filtration rate (GFR).
To further investigate the possibility of an autoimmune
etiology, particularly of IgG4-SC, a liver CNB was obtained
(Figure 2). The liver biopsy had a length of 60 mm and
contained 32 portal tracts. Twenty-four of the portal tracts
showed chronic (mainly lymphoplasmacytic) inflammation,
some of them with weak or moderate interphase activity.
A portal-based, expansile inflammatory nodule (IN) mea-
suring 6 mm in largest dimension, leading to expansion
of a portal tract due to storiform fibrosis and lymphoplas-
macytic infiltration, was identified (Figures 2(a) and 2(b)).
Numerous myofibroblasts, immunohistochemically positive
for smooth-muscle antigen, were observed in the IN (data
not shown). No accumulation of neutrophilic granulocytes
was found, and granulomas and multinucleated giant cells
were lacking. In the bile duct located inside the IN, strong
infiltration with lymphocytes and plasma cells was observed
(Figure 2(c)). The bile duct mucosa was intact, without
erosion or ulceration. The epithelium was mainly monolay-
ered, but focally with slight hyperplasia. The epithelial cells
were cylindric, and only focally slight variation of nuclear
size was observed. Additionally, at some sites, a notable
degree of obstructive cholestasis was found. Obliterative
phlebitis was identified (Figures 2(d) and 2(e)) and, in addi-
tion, venolitis. Immunohistochemically, there was diffuse
infiltration with IgG4-positive plasma cells (Figure 2(f)).
Hot spots revealing 339 IgG4-positive and 468 IgG-positive
plasma cells per high power field (HPF, 0.2 mm2) were
found, corresponding to an IgG4/IgG ratio of 72% (Figures
2(g) and 2(h)). Moreover, microscopy showed several portal
tracts with moderate periductal fibrosis and inflammatory
infiltrates dominated by lymphocytes and plasma cells and
associated with eosinophilic granulocytes (in hot spots up
to 13 /HPF). In the light of these findings, the diagnosis
of IgG4-SC involving the extra- and intrahepatic small bile
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Figure 1: Imaging findings in a patient with IgG4-related sclerosing cholangitis (IgG4-SC). (a) Atmagnetic resonance imaging, no tumor-like
lesions are seen. A benign hepatic cyst is indicated (1). (b) Diffuse and multiple intrahepatic biliary stenoses and dilatations at endoscopic
retrograde cholangiography (1). The stenoses are relatively long. In classical primary sclerosing cholangitis (PSC), the stenoses would have
been shorter, giving the cholangiogram a more beaded appearance. No complete obstruction of a bile duct is seen, a finding that would have
been more characteristic of bile duct carcinoma. 2: occlusive balloon, 3: endoscope, 4: guide wire.
ducts was suggested. At this time, it was speculated whether
the patient also had IgG4-positive autoimmune pancreatitis
(AIP) type 1, another manifestation of IgG4-RD that is often
associated with IgG4-SC. However, the main pancreatic duct
was unremarkable by MRCP, the amylase was not elevated,
no focal or diffuse enlargement of the pancreas or delayed
enhancement was found at c-CT, and calcifications and cysts
are usually not a feature of AIP. Hence, the International
Consensus Diagnostic Criteria (ICDC) for AIP were not
fulfilled [9]. Other lesions frequently associated with IgG4-
SC are IgG4-related retroperitoneal fibrosis and IgG4-related
thyroiditis, but these manifestations were not present in our
patient [10, 11].
The inguinal lymph node that was surgically removed
two months before debut of the gastrointestinal symptoms
was initially classified as reactive with nodular lymphoid
hyperplasia and smaller areas with nonnecrotic granulo-
matous inflammation. The lymph node was retrieved from
the archive and showed expanded interfollicular zones as
well as follicular hyperplasia with activated germinal centers
(Figure 3(a)). Interfollicular zones as well as follicles were
infiltrated by an increased number of plasma cells (Fig-
ure 3(b)). In several foci, the germinal centers were pene-
trated by small venules. Immunohistochemically, hot spots
revealing 593 IgG4-positive and 646 IgG-positive plasma cells
per high power field (HPF, 0.197-0.199 mm2) were found,
corresponding to an IgG4/IgG ratio of 92% (Figures 3(c)
and 3(d)). Based on the above, it was assumed that the
patient had IgG4-related lymphadenopathy associated with
IgG4-SC. Interestingly, there were a few smaller areas with
a characteristic granulomatous inflammation. These granu-
lomatous foci were arranged in a ring-like fashion around
lymphoid follicles, a feature also called perifollicular gran-
uloma (Figure 3(e)). Epitheloid granulomas usually make a
diagnosis of IgG4-RD unlikely [1]. However, perifollicular
granulomas are an exception, as they have been reported in
a number of cases of IgG4-related lymphadenopathy [12–
15]. Figure 3(f) shows that the perifollicular granulomas
were accompanied by numerous IgG4-positive cells. Of note,
perifollicular granulomas are not specific for IgG4-related
lymphadenopathy and can also be observed in, for example,
nodular lymphocyte predominance Hodgkin lymphoma or
reactive lymph nodes of unknown etiology [12].
The patient began combined treatment with a daily dose
of 100 mg azathioprine and 37.5 mg prednisolone. Within
one month, the daily dose of prednisolone was tapered
to 12.5 mg. Liver enzymes and AP decreased further after
initiation of medical treatment. The dose of prednisolone
was whatsoever not tapered continuously due to his muscle
disease that seemed to improve due to steroids. The patient
stopped with prednisolone 16 months after initiation of the
immunosuppressive treatment and now, 26 months later,
he is stable without recurrence, taking 150 mg azathioprine
daily. However, at present, it is considered to increase his
insulin dose, as the blood glucose levels are suboptimal.
Unfortunately, no follow-up imaging was performed. Instead,
AP, ALT, and immunoglobulins were checked regularly and
are currently normal.
3. Discussion
The case presented here emphasizes that clinically and
cholangiographically, IgG4-SC resembles bile duct carci-
noma and PSC in many aspects. The diagnostic process is
therefore based on close cooperation between the treating
gastroenterologist, surgeon, radiologist, and pathologist. Due
to its usually good response to steroid treatment and the
dismal prognosis of its two main differential diagnoses,












Figure 2: Liver core needle biopsy findings in a patient with IgG4-related sclerosing cholangitis (IgG4-SC). (a) A portal inflammatory nodule
(IN), showing storiformfibrosis (arrows) anddiffuse lymphoplasmacytic infiltration (H&E). (b)Highermagnification of the storiformfibrosis
(H&E). (c) Strong infiltration of lymphocytes and plasma cells in the wall of the bile duct (Methyl-Green Pyronin). (d) Deeper section of the
same area shown in Figure 2(a). At the periphery of the IN, there is obliterative phlebitis (arrows). Note the wall of the corresponding artery
(Verhoeff elastin). (e) Higher magnification of the area with obliterative phlebitis shown in Figure 2(d).The former lumen of the vein is filled
with plasma cells and lymphocytes. The vein can only be identified using an elastin stain (Verhoeff elastin). (f) Deeper sections of the area
shown in Figure 2(a). Strong infiltration of IgG4-positive cells in the IN. (g, h) The IgG4 / IgG ratio is 72%.
the correct diagnosis of IgG4-SC is of high importance.
Frequently, IgG4-SC is associated with autoimmune pan-
creatitis (AIP) type 1 or other manifestations of IgG4-RD
[16, 17]. Clinically and demographically, patients with IgG4-
SC are mainly middle-aged to elderly males, debuting with
obstructive jaundice, weight loss, steatorrhea, and abdominal
pain, similarly to extrahepatic/hilar bile duct cancer [2, 18].
Serum IgG4 is elevated in most cases of IgG4-SC but is not
a fully reliable adjunct in the differential diagnosis, as it also
may occur in some patients with PSC and cancer and as its
sensitivity is only around 90% [19, 20]. Cholangiographically,
IgG4-SC also imitates PSC or bile duct carcinoma, as in the
case presented here [21]. However, the diffuse distribution
of the bile duct changes in our case was more suggestive
of an inflammatory disease than bile duct carcinoma, and
there was no complete obstruction. A focal concentric
bile duct wall thickening with dilatation of the peripheral
bile ducts, as well as complete obstruction of a bile duct,
had been more suggestive of bile duct carcinoma [22, 23].
Cholangiographically, IgG4-SC was more likely than PSC
because the stenoses were relatively long, while in classical
PSC, the strictures are usually more band-like and shorter
than the dilated segments, leading to a beaded appearance
[24]. An IgG4-SC study by Naitoh et al. indicated that
involvement of the peripheral small intrahepatic bile ducts
correlates with intrahepatic biliary strictures at ERCP [8].




Figure 3: Histological findings in a patient with IgG4-related lymphadenopathy. (a) Low magnification showing expansion of the
interfollicular zone (H&E). (b) At highermagnification, numerous plasma cells are identified in the interfollicular zones (H&E). (c, d) Strong
infiltration of IgG4-positive cells, hot spot (c) (IgG4 immunostaining) and IgG-positive cells, hot spot (d) (IgG immunostaining).The IgG4 /
IgG ratio is 92%. (e) A granulomatous focus, arranged in a ring-like fashion around a lymphoid follicle, is shown, a feature called perifollicular
granuloma (H&E). (f) Another perifollicular granuloma, accompanied by numerous IgG4-positive cells (IgG4 immunostaining).
In these cases, there is a higher probability that a liver
CNB will yield features diagnostic of IgG4-SC [8]. A liver
CNB likely diagnostic of IgG4-SC must show at least two
of the three “Boston criteria”: storiform fibrosis, obliterative
phlebitis and dense lymphoplasmacytic infiltration, and the
absence of features advocating against this diagnosis, such
as malignancy, necrosis, or multinucleated giant cells [1].
Increased IgG4-positive plasma cells (in a liver CNB at least 10
IgG4-positive plasma cells/HPF) and an increased IgG4/IgG
ratio (>40%) can further support a diagnosis of IgG4-SC
[1, 6]. The diagnostic criteria for IgG4-SC, as published by
the Japanese Working Group, include characteristic biliary
imaging findings, elevated serum IgG4, other organ mani-
festations of IgG4-RD, and characteristic histopathological
features [6].The current case report also met these diagnostic
criteria. A study by Chen and Deshpande, aimed at differ-
entiating between IgG4-SC and PSC based on liver CNB,
reported that an expansile portal-based inflammatory nodule
(IN) was found in half of the IgG4-SC cases (n=10) but in
none of the PSC cases (n=17) [7]. The IN was composed
of lymphocytes, plasma cells, eosinophils, fibroblasts, and
a storiform fibrosis, similar to the case presented here [7].
Naitoh reported an IN in a liver CNB from a patient with
IgG4-SC (one of 19 IgG4-SC patients) [8]. In the present
case, we identified a portal vein and a hepatic artery in the
IN. Hence, it is unlikely that the IN represented an IgG4-
positive inflammatory pseudotumor (IgG4-IPT), another
IgG4-related lesion that can occur in the liver [25]. In patients
without cholangiographic intrahepatic bile duct strictures but
involvement of the extrahepatic bile ducts, a cholangioscopic
bile duct forceps biopsy can sometimes be of diagnostic
value [26]. However, in patients who underwent stenting
prior to bile duct biopsy, reactive epithelial changes may be
present that can imitate neoplastic changes. The hallmarks
of IgG4-SC, namely, storiform fibrosis, obliterative phlebitis,
and increased IgG4-positive cells, are often located deep in
the bile duct wall and may therefore often be missed in bile
duct biopsy specimens, which are often superficial and tiny
and only contain limited amounts of subepithelial connective
tissue.Themere presence of subepithelial lymphoplasmacytic
infiltrates showing IgG4-positivitymay support a diagnosis of
IgG4-SC in some instances, but can also be present in cases of
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bile duct cancer and even PSC [27, 28]. Hence, for the biopsy
diagnosis of IgG4-SC, as for other organ manifestations of
IgG4-RD, a frequent limitation is the scarcity of the tissue
specimens available for the diagnosis, which may prevent a
clear-cut diagnosis [5].
IgG4-related lymphadenopathy is both an “under- and
overdiagnosed entity”, asmentioned byCheuk et al. [12]. Five
different histological patterns (I-V) have been reported as
part of its morphological spectrum [12]. Most of the features
overlap and are present in more than just one of the reported
patterns, although the interfollicular expansion found in our
case seems to be present in only pattern III [12]. Due to the
low specificity of the morphological features in IgG4-related
lymphadenopathy, as obliterative phlebitis and storiform
fibrosis are often not present, an IgG4/IgG ratio > 40% and
more than 100 IgG4-positive cells per HPF are essential for
its diagnosis [12]. However, many other conditions, such as
Rosai-Dorfman disease, multicentric Castleman disease, or
rheumatoid arthritis, may show increased IgG4-positive cells
and an increased IgG4/IgG ratio [12].Therefore, an increased
serum IgG4 value and/or extranodal manifestations of IgG4-
RD should be present [12]. The current case shows both
the morphological characteristics and meets the threshold
of IgG4/IgG ratio and IgG4-positive cell count. Besides, the
patient developed symptoms of IgG4-SC two months after
surgical removal of the lymph node, and at that time, he had
a serum IgG4 value ten times above upper limit of normal.
Therefore, the diagnosis of IgG4-related lymphadenopathy
seemed reasonable in our patient.
Our patient was diagnosed with malignant melanoma
and basal cell carcinoma 4.5 and 1.5 years prior to the
development of IgG4-RD. It is at present not clear whether
IgG4-RD may be a form of paraneoplastic syndrome in
patients with malignancies. A few follow-up studies indicate
an increased risk for the development of malignancies in
IgG4-RD, including patients with type 1 AIP and IgG4-SC
[29–31]. However, a Japanese study from 2014 reported no
increased incidence in total number of malignancies between
patients with IgG4-RD and the general population [32]. Two
studies based on European patients reported a relatively high
cumulative frequency of malignant diagnoses prior to or
after a diagnosis of type 1 AIP (14.3% and 25%) [33, 34].
Further studies, however, are needed to elucidate the risk of
malignancies in IgG4-RD.
Thepatient presented here had unspecifiedmyopathy and
noticed a marked improvement related to treatment of IgG4-
RDwith steroids. It is well known that inflammatory myopa-
thy responsive to steroids can develop in association with
autoimmune diseases such as systemic sclerosis, systemic
lupus erythematosus, Sjo¨gren’s syndrome, and rheumatoid
arthritis, a condition termed overlap myositis [35]. Hence,
one may speculate whether there may be a pathophysiologic
relation between IgG4-RD and the myopathy in our patient.
Unfortunately, no muscle biopsy, the gold standard for
diagnosing overlap myositis, was obtained in our patient
[35]. However, to our knowledge, autoimmune liver and bile
duct diseases are only very rarely associated with myopathies.
Besides, apart from IgG4-related orbital myositis, myosi-
tis is not a well described manifestation of IgG4-RD [1].
Recently, in a patient diagnosed with polymyositis, elevated
serum IgG4 and infiltration of IgG4-positive cells in the left
quadriceps muscle were reported, and it was concluded that
polymyositis may be a mimicker of IgG4-RD [36]. Hence, it
is most likely that the myopathy in our patient was unrelated
to IgG4-RD.
In conclusion, we present a case of a male with IgG4-
related sclerosing cholangitis involving the small intrahepatic
as well as the hilar bile ducts, initially suspected to represent
bile duct cancer, diagnosed with liver biopsy, and associated
with IgG4-related lymphadenopathy.
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